Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carlos Lacalle-González
Observed names:
C. Lacalle-González,
Carlos Lacalle-Gonzalez
Institution:
Hospital Universitario Fundación Jiménez Díaz
Observed institutions:
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
IDCQ Hospitales y Sanidad, S.L.U.,
Universidad Autónoma de Madrid
ORCID:
0000-0002-7690-399X
Observed ORCID:
0000-0002-7690-399X
OpenAlex ID:
A5045805543
Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment
2024
·
Paula Iglesias-Matesanz
, Carlos Lacalle-Gonzalez
, et al.
·
Antioxidants
·
21
Iron-Dependent Cell Death: A New Treatment Approach against Pancreatic Ductal Adenocarcinoma
2023
·
Carlos Lopez-Blazquez
, Carlos Lacalle-Gonzalez
, et al.
·
International Journal of Molecular Sciences
·
15
PDF
DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer
2023
·
Carlos Lacalle-Gonzalez
, Maria Florez-Cespedes
, et al.
·
Biomedicines
·
7
PDF
Dormancy in Colorectal Carcinoma: Detection and Therapeutic Potential
2025
·
Sofía Fernández-Hernández
, Miguel Ángel Hidalgo-León
, et al.
·
Biomolecules
·
5
PDF
Management of non-hepatic distant metastases in neuroendocrine neoplasms
2023
·
C. Lacalle-González
, A. Estrella Santos
, et al.
·
Best Practice & Research Clinical Endocrinology & Metabolism
·
4
Post-Chemotherapy Rebound Thymic Hyperplasia Mimicking Relapse in Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report
2021
·
Alberto Lazaro-Garcia
, Carlos Lacalle-Gonzalez
, et al.
·
Oncology Research and Treatment
·
3
FOLFIRINOX Combined with GPX4 Inhibition Induces Ferroptosis and Defines Redox-Based Therapeutic Subgroups in Pancreatic Cancer
2025
·
Carlos Lacalle-Gonzalez
, Carlos Lopez-Blazquez
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations
2026
·
Alberto Orta
, Miguel Angel Hidalgo-Leon
, et al.
·
Frontiers in Pharmacology
PDF
Show more works
View as search
Works count:
8
Citation count:
56
H-index:
4
I10-index:
2
Year
Topic
Type